We are live on ! Find out more
RVMDW icon

Revolution Medicines Inc Warrant

Fund managers haven’t disclosed any holdings of RVMDW yet.

RVMDW Hedge Fund Activity: Q1 2026 in Review

23 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in Revolution Medicines Inc Warrant (RVMDW) for Q1 2026, worth a combined $18.1M — up 118% from $8.31M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of RVMDW and 2 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 6 added.

The largest buyer was Sculptor Capital, adding an estimated $1.51M. The largest seller was Soros Capital Management, exiting entirely with an estimated $343K sold.

  • 23 institutional investors held Revolution Medicines Inc Warrant (RVMDW) as of Q1 2026, down from 24 in Q4 2025.
  • Funds reported $18.1M of Revolution Medicines Inc Warrant stock for Q1 2026, up 118% quarter-over-quarter.
  • 2 funds opened new Revolution Medicines Inc Warrant positions in Q1 2026 and 3 closed out, a net change of -1 holder.
  • The largest Revolution Medicines Inc Warrant buyer in Q1 2026 was Sculptor Capital, an estimated $1.51M added.
  • The largest Revolution Medicines Inc Warrant seller in Q1 2026 was Soros Capital Management, an estimated $343K sold.

Based on aggregated 13F filings for Q1 2026.